cd5l promot m2 macrophag polar autophagy-medi upregul id3 march 2018 | volum 9 | articl 4801 origin research published: 12 march 2018 doi: 10.3389/fimmu.2018.00480 frontier immunolog | www.frontiersin.org edit by: liwu li, virginia tech, unit state review by: charl e. mccall, wake forest baptist medic center, unit state joan clria, hospit clnic barcelona, spain *correspondence: maria-rosa sarria specialti section: articl submit molecular innat immunity, section journal frontier immunolog received: 09 januari 2018 accepted: 23 februari 2018 published: 12 march 2018 citation: sanjurjo l, aran g, tllez , amzaga n, armengol c, lpez d, prat c sarria m-r (2018) cd5l promot m2 macrophag polar autophagy- mediat upregul id3. front. immunol. 9:480. doi: 10.3389/fimmu.2018.00480 cd5l promot m2 macrophag polar autophagy- mediat upregul id3 luca sanjurjo1,2, gemma aran1, rica tllez1, nria amzaga1, carolina armengol3,4, daniel lpez5, clara prats5 maria-rosa sarrias1,3* 1 innat immun group, german tria pujol health scienc research institut (igtp), barcelona, spain, 2 network biomed research diabet associ metabol disord (ciberdem), barcelona, spain, 3 network biomed research hepat digest diseas (ciberehd), barcelona, spain, 4 childhood liver oncolog group, program predict person medicin cancer (pmpcc), german tria pujol health scienc research institut (igtp), badalona, spain, 5 departa fsica, escola superior dagricultura barcelona, universitat politcnica catalunya barcelonatech castelldefels, barcelona, spain cd5l (cd5 molecule-like) secret glycoprotein control kei mechan inflammatori responses, involv process infection, atherosclero- sis, cancer. macrophages, cd5l promot anti-inflammatori cytokin profil respons tlr activation. present study, question cd5l abl influenc human macrophag plasticity, drive polar specif phenotype. compar cd5l-induc phenotyp function chang caus ifn/lps, il4, il10 human monocytes. phenotyp marker quantifi rt-qpcr flow cytometry, mathemat algorithm built analysis. moreover, compar ro production, phagocyt capacity, inflammatori respons lps. cd5l drove cell polar similar induc il10. furthermore, il10- cd5l-treat macrophag show increas lc3-ii content coloc acid compartments, point enhanc autophagy-depend processes. accordingly, sirna target atg7 thp1 cell block cd5l-induc cd163 mer tyrosin kinas mrna efferocytosis. cells, gene express profil valid indic upregul transcript factor id3 cd5l atg7. agreement, id3 silenc revers polar cd5l. data point signific contribut cd5l-mediat autophagi induct id3 provid evid cd5l drive macrophag polarization. keywords: cd5l, autophagy, macrophag polarization, scaveng receptor cystein rich, mathemat algorithm, id3, phagocytosis, efferocytosi introduct macrophag innat immun cell present vertebr tissues. ensur homeostasis, cell respond intern extern cue exert trophic, regulatory, repair, effector func- tion (1). however, involv pathogenesi major human diseases, rang infections, atherosclerosis, chronic inflammatori diseas includ arthriti diabetes, degen condit alzheim disease, cancer (2). 2 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 function divers macrophag attribut abil alter phenotyp respons chang microenviron (3). plastic allow acquir wide rang functions, proinflammatory, pathogen- eliminating, subsequ tissue-damag (refer m1 classic activ macrophages) anti-inflammatory, immunosuppressive, wound-heal (refer m2 altern activated) (4). context given inher- ent plastic cells, grow appli knowledg polar treat human diseases. regard, repolar macrophag offer attract therapeut approach diseas cancer (5). subpopul polar macrophag defin basi vitro stimulation. m1 prototyp macrophag induc th1 inflammatori cytokines, microbi factors, combin two. turn, m2 subset compris macrophag induc exposur th2 cytokin il4 il13, immun complex combin il1 lps, glucocorticoids, anti-inflammatori cytokin il10 tgf, tumor microenvironment factor il6 leukemia inhibitor factor (6, 7). here, adopt macrophag nomenclatur propos murrai et al. base activ stimulus, i.e., m-inf/lps, m-il4, m-il10, m-dexamethason (dxm), refer m1, m2a, m2c, respect (8). mac- rophag subset classifi basi gene signatures, activ signal pathways, surfac molecul express pattern, secretori profile, function properti (6, 7, 912). however, regard, studi perform murin models. model led great advances, import discrep human. moreover, inform human macrophag polar limit scattered, especi function characterization. observ highlight urgent need advanc knowledg human macrophag polar (5). macrophag main sourc cd5-like protein (cd5l), 40-kda solubl glycoprotein belong scaveng receptor cystein rich superfamili (13). cd5l involv broad spectrum biolog function (14). mous model diseas support notion cd5l particip pathogenesi inflammatori processes, includ cancer, prevent apoptosi macrophag cell type (1520). human cd5l shown modul aspect macrophag biology, anti-microbi respons mycobacterium tuberculosi (21) tlr activ increas autophag mechan (22, 23). moreover, cd5l contribut atherogenesi promot oxldl uptak macrophage-endotheli cell adhes (24). cd5l circul serum rel high amount (25), result proteom profil highlight put serum biomark inflammatori condit atop dermat (26), kawasaki diseas liver cirrhosi (2729). signific alter plasma cd5l levels, report control macrophag responses, consist suggest function role protein host inflammatori reactions. like kei modul macrophag activity, cd5l express tightli regul cell tissu (20, 30, 31), upregul inflammatori condit dur- ing cardiovascular metabol pathologies. likewise, vitro cultur macrophag express cd5l previous activ specif stimuli (19, 24, 32). here, studi involv cd5l human mac- rophag polarization. end, perform comprehens analysi human macrophag polar vitro. novel mathemat algorithm analyz phenotyp changes, function studies, reveal time thatlik il10cd5l drive macrophag m2 phenotype. addition, cd5l express restrict macrophag treat il10. furthermore, result provid evi- denc cd5l involv m2 macrophag polar depend autophag mechan id3 transcript factor. materi method primari cell cell line studi involv human sampl conduct follow declar helsinki principl current legisl confidenti person data approv human ethic committe hospit universitari german tria pujol. buffi coats, provid blood tissu bank (barcelona, spain), obtain healthi blood donor follow institut standard oper procedur blood donat processing, includ inform consent. cd3+ cell deplet rosettesep human cd3 deplet cocktail (stemcel technologies). peripher blood mononuclear cell (pbmc) isol describ previous (23) ficoll-paqu (ge healthcare) densiti gradient centrifug 400 g 25 min. recov cell wash twice pb count perfect-count microspher (cytognos), follow manufactur instructions. peripher blood monocyt (pb monocytes) isol adher 5% co2 incub 37c rpmi-1640 2 mm glutamin (lonza) supplement 10% heat-inactiv human ab serum (sigma-aldrich) 30 min. non-adher cell remov adher cell wash twice pb incub rpmi-1640 2 mm glutamine, 10% heat-inactiv fetal bovin serum (fbs, lonza), 100 u/ml penicillin, 100 g/ml streptomycin (sigma- aldrich) 24 h prior experiments. percentag adher cd14+ cell (pb monocytes) routin obtain 94.98% (3.26%). phagocytosi assays, pb monocyt differenti incub rpmi 10% heat-inactiv fb 7 dai prior experiments, describ previous (24). stabli transfect thp1-vector thp1-cd5l cell line gener describ amzaga et al. (24). cell grown cultur medium (rpmi-1640 2 mm glutamine, 100 u/ ml penicillin, 100 g/ml streptomycin) supplement 10% heat-inactiv fb 250 g/ml geneticin (gibco). prior experiments, cell differenti macrophag incub 10 ng/ml phorbol 12-myrist 13-acet (pma, sigma-aldrich) cultur medium 24 h. 3 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 wash pb grown cultur medium 24 h. cell refer thp1. hepg2 cell purchas atcc (the american type cultur collection) cul- ture emem supplement 2 mm glutamin (lonza), 100 u/ml penicillin, 100 g/ml streptomycin, 10% heat- inactiv fbs. vitro polar macrophag pb monocyt thp1 macrophag polar incub indic time 50 ng/ml ifn (preprotech) plu 100 ng/ml lp escherichia coli o111:b4 (sigma-aldrich) (inf/lps), 40 ng/ml il4 (preprotech), 50 ng/ ml il10 (preprotech), 40 ng/ml dxm (kern pharma). control popul incub cultur medium () polar cytokines. assess effect human cd5l (homo sapien cd5l, hscd5l) pb monocytes, cell incub 1 g/ml albumin (alb) purifi human plasma (grifols), control protein, 1 g/ml endotoxin-fre recombin cd5l (rcd5l) express chines hamster ovari cells, detail ref. (24). posit control cd5l mrna upregulation, cell treat 1 m t1317 (tocri bioscience, bristol, uk), plu 1 m 9cra (sigma-aldrich). multicolor flow cytometri analysi pb monocyt (106 cells/well) plate six-wel plate incub 72 h polar stimuli final concentr 5% fbs. detach accutas (sigma-aldrich), wash pbs, incub 100 l block buffer [pb contain 10% human ab serum (sigma- aldrich), 2% fc (lonza), 0.02% nan3 (sigma-aldrich)]. cell label brilliant stain buffer (bd bioscience) combin fluoresc conjug monoclon antibodi hladr, cd80, cd23, cd206, cd163 (bd biosciences). flow cytometri analysi perform bd lsrfortessa instrument facsdiva softwar (bd biosciences), 10,000 event acquir sample. integr median fluoresc intens (imfi) comput multipli rel frequenc (percentag positive) cell express marker median fluoresc intens (mfi) cell population. algorithm develop classif polar macrophag basi phenotyp respons ifn/lps, il4, il10 donor d (d = 1:26), defin vector includ imfi measur surfac marker certain stimulu st (st = ifn/lps, il4, il10) imfid,st = ( )imfi imfi imfi imfi imfihladr cd80 cd23 cd206 cd163, , , , dd ,st (1) mean respons sampl specif stimulu calcul written correspond vector. therefore, stimulu obtain mean vector, contain mean valu imfi measurements, surfac marker. imfimean,st = { } { }(mean imfi mean imfi mean imfi hladr cd80 cd , ,, ,d d 223 cd2016 cd163 stmean imfi mean imfi, , ,, ,d d d{ } { } { }) (2) given (i) presenc surfac marker mem- brane result fluoresc intens scale differ marker (ii) sought simpli determin tendenc surfac marker increas decreas certain stimulus, defin normal scale imfi markers, obtain normal imfi, imfi. carri normalization, took maximum refer- enc valu surfac marker aris mean vectors, imfimean, st . normal appli individu measur valu (i.e., donor, stimulus, surfac marker) follows, fix 1 valu exceed it: imfi min imfi max imfi sm sm sm,mean, st ifn lp il4 il , , / , d d= { } = 11 sm hladr, cd80, cd23, cd206, cd163 0 1; ; = (3) normal algorithm appli mean vectors, obtain dimensionless mean vector respons pattern stimuli, imfi pattern,st , shown figur 1b. imfi pattern, st = imfi ,imfi ,imfihladr, mean cd80, mean cd( 223, mean cd206, mean cd163, mean st , imfi ,imfi ) . (4) respons pattern classifi sampl respons given stimulus. hypothes sampl stimul ifn/lp lowest distanc ifn/lp pattern ( )imfi pattern,ifn / lp respons compar il4 pattern ( )imfi pattern,il4 il10 pattern ( )imfi pattern,il10 . let assum sampl certain donor, d, treat stimulu st (st = ifn/lps, il4, il10). sampl experiment analyz surfac marker determined. normal concentra- tion surfac marker evalu vector imfi st, d = imfi , imfi , imfi , imfhladr, cd80, cd23, ( d d d ii ,imficd206, cd163, st d d ) . magnitud set compar pattern geometr distanc vectors, diststifn/lps, d, diststil4, d, diststil10, d, follows: distst ifn/lp = ,d imfi imfit,d pattern,ifn / lp s (5) distst il = 4,d imfi imfist,d pattern,il4 (6) distst il = 10,d imfi imfist,d pattern,il10 (7) sampl classifi basi minimum distance, i.e., sampl stimul ifn/lps, expect min dist dist dist distst ifn lp st il st il st { } =/ , , ,, ,d d d4 10 nn/lps,d. 4 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 figur 1 | continu tabl 1 | algorithm classifi sampl n treat unknown stimulus. (1) experiment determin imfi n vector stimul sampl (n) mean flow cytometry, includ measur surfac marker (imfi , imfi ,imfi , imfi , imfihladr. cd80. cd23. cd206. cd16n n n n 33.n ) (eq. 1). (2) evalu normal concentr vector, imfi n, normal factor given eq. 3. (3) evalu geometr distanc imfi n pattern vector ( , , )imfi imfi imfipattern,ifn/lp pattern,il4 pattern,il10 (eq 57). (4) classif sampl accord minimum distanc criterion: min dist dist distifn/lp il4 iln n n { }, , 10 . figur 1 | cd5l induc phenotyp macrophag like il10. (a) multicolor flow cytometri analysi hladr, cd80, cd23, cd206, cd163 marker profil pb monocyt treat 72 h medium (), standard polar stimuli (inf/lps, il4, il10), recombin cd5l (cd5l), albumin (alb) human serum. graph integr median fluoresc intens (imfi) valu maker. data 28 12 blood donor standard stimuli rcd5l/alb included, respectively. (b) normal profiles. mean respons pattern monocyt stimuli, repres normal vector imfi pattern,st (st = m, ifn/lps, il4, il10, cd5l). standard stimuli: n = 26, rcd5l/alb n = 12. (c) distanc sampl respons normal profiles. blue: distanc ifn/lp pattern (diststifn/lps,d); orange: distanc il4 pattern (diststil4,d); green: distanc il10 pattern (diststil10,d). sampl 12 blood donor stimul ifn/lps, il4, il10, cd5l included. (d) pb monocyt treat 24 h, mrna encod cd80, tnf, cd206, tgm2, cd163, mer tyrosin kinas (mertk), cd36, vascular endotheli growth factor (vegf) measur rt-qpcr. data mean blood donors. (e) thp1 macrophag incub indic stimuli 24 h, mrna encod cd80, tgm2, cd163, mertk measur rt-qpcr. data mean independ experiments. (f) western blot imag pb monocyt incub 24 h human albumin (alb), rcd5l il10 (left), thp1-vector, thp1-cd5l macrophag (right) probe specif antibodi phosphoryl stat3 (tyr705), stat3, tubb2a. repres blot independ experiments. (a,d,e), data present mean sem. *p 0.05; **p 0.01; ***p 0.001 student t-test, vs. macrophag cultur medium () column. tabl 2 | list primer study. gene forward primer (5 3) revers primer (5 3) cd80 ctgcctgacctactgctttg ggcgtacactttcccttctc tnf gaggaggcgctccccaagaag gtgaggagcacatgggtggag tgm2 cctcgtggagccagttatcaa gtctgggatctccaccgtcttc cd206 acacaaactgggggaaaggtt tcaaggaagggtcggatcg cd163 caccagttctcttggaggaaca tttcacttccactctcccgc mertk ctctggcgtagagctatcact aggctgggttggtgaaaaca cd36 gagaactgttatggggctat ttcaactggagaggcaaagg vegf agggcagaatcatcacgaagt agggtctcgattggatggca cd5l gacgagaagcaacccttcag cccagagcagaggttgtctc atg7 atgatccctgtaacttagccca cacggaagcaaacaacttcaac bex1 aggcccaggagtaatggagt aaccgcctacgatttcctct id3 gagaggcactcagcttagcc tccttttgtcgttggacatgac gapdh tcttcttttgcgtcgccag agccccagccttctcca 5 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 procedur appli assess distanc respons cell cd5l pattern (distcd5lifn/lps, d, distcd5lil4, d, distcd5lil10, d), normal- iz imficd5l,d obtain mean eq. 3 (d = 1:12). valu distanc shown figur 1c. complet algorithm classifi stimul sampl summar tabl 1. rna extract quantit rt-pcr pb monocyt thp1 macrophag (1 106 cells/well) incub 24 h rpmi medium contain 5% fc polar stimuli. cell wash pb disrupt qiazol lysi reagent (qiagen), rna extract mirneasi mini kit (qiagen). total rna (1 g) revers transcrib rna cdna ecodri premix (clontech). rt reaction amplifi lightcycl 480 pcr (roche) kapa sybr fast master mix (kapa biosystems). sampl incub initi denatur 95c 5 min, 40 pcr cycl perform follow conditions: 95c 10 s, 60c 20 s, 72c 10 s. primer pair studi list tabl 2. gene express valu normal express level gapdh (glyceraldehyd 3-phosphat dehydrogenase). fold induct level calcul express level gene untreat condit () reference. measur cytokin secret pb monocyt (105 cells/well) incub 72 h polar stimuli dilut cultur medium contain 5% fc subsequ stimul lp (from e. coli 0111: b4, sigma-aldrich). 4 h (for tnf) 24 h (il1 il6), cultur supernat fraction collect assai cytokin product opteia elisa, follow manufactur instruct (bd biosciences). experi thp1 macrophag treat sirna target id3 expression, cell sirna-transfect allow dif- ferenti (see below). stimul lp (5 104 cells/well) assai cytokin product above. color develop ad 3,3,5,5-tetramethylbenzidin liquid substrat (sigma-aldrich). optic densiti read 450 nm varioskan flash micropl reader (thermofish scientif inc.). ro measur pb monocyt (105 cells/well) polar indic stimuli 72 h load 10 m dichloro-dihydro- fluorescein diacet (h2-dcf-da) (sigma-aldrich) pb 30 min 37c dark. wash twice resuspend 100 l pbs. absorb 485 nm meas- ur varioskan flash micropl reader (thermofish scientif inc.). intracellular ro level calcul level control cell () reference. analysi phagocytosi flow cytometri 2.5 105 pb monocyt thp1 macrophag plate 24-well plates, polar 72 h incub 3 m 6 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 yg fluoresbrit microspher (polysciences), e. coli k-12, staphylococcu aureu fluoresc bioparticl (molecular probes) indic ratio (macrophage: microsphere/bacteria) 1 h 37 4c. incub 4c perform measur extracellular attach internalization, uptak occur temperature. cell harvest 20-min incub accutas (sigma-aldrich). extens wash cold pb fix pb con- tain 4% paraformaldehyd (panreac) 30 min. phagocytosi quantifi flow cytometri facscantoii instrument (bd bioscience) facsdiva softwar (bd bioscience). induct apoptosi efferocytosi assai 1 106 hepg2 cell plate six-wel plate label 5 m celltrac cfse (invitrogen) pb 20 min 37c 5% co2. wash medium replac emem 10% fbs. twenty-four hour later, apoptosi induc 45 min uv irradi follow 1 h rest 37c. 3,3-dihexyloxacarbocyanin iodid (dioc, sigma-aldrich) propidium iodid (pi; sigma-aldrich) measur apoptosi flow cytometry, obtain 16.2% 8.1% live cell (dioc+, pi), 9.4% 5.0% earli apoptot cell (dioc, pi), 68.3% 5.2% late apoptot cell necrot cell (pi+). efferocytosi assai perform co-cultur thp1 cell pre-labeled, 0.5 m celltrack deep red dye (thermo fisher), cfse-label apoptot hepg2 cell 1 h indic ratio (macrophage: apoptot cell) 37 4c. cell harvest 20-min incub accutas (sigma-aldrich), extens wash cold pbs, fixed. flow cytometri perform facscantoii instru- ment. facsdiva softwar quantifi percentag deep red-label macrophag phagocytos cfse-label apoptot cells. addition, efferocytosi observ fluo- rescent microscopi axio observ z1 duo lsm 710 confoc (carl zeiss microscopi gmbh). western blot analysi cell lysat stat3 phosphorylation, lc3 convers id3 detect analysis, pb monocyt thp1 macrophag (1 106 cells/well) plate six-wel plate polar incub indic stimuli 37c indic periods. wash cold tb lyse tb lysi buffer [20 mm tris, ph 7.5, contain 150 mm nacl, 1 mm edta, 1 mm egta, 1% triton x-100, 1 mm na3vo4, 1 mm pmsf, complet proteas inhibitor cocktail (all sigma-aldrich)] 30 min 4c. stat3 lc3, nuclei cell debri remov cen- trifug 8,000 g 15 min, id3, total cell lysat resolved. protein concentr measur bca protein assai reagent kit (thermo fisher scientific), follow manufactur instructions. end, 4050 g protein cell lysat resolv 10% sds-polyacrylamid gel (12% lc3) reduc condit electrophoret transfer nitrocellulos membran (bio-rad laboratories). block start block tb buffer (thermo fisher) 1 h room temperatur incub overnight 4c mab anti-phosphoryl stat3 tyr705 (clone 9e12, 05-485, millipore), poab anti-stat3 (06-596, millipore), poab anti-lc3 (nb1002220, novu biologicals), mab anti-id3 (9837, cell signal technology) dilut block buffer. blot probe beta-tubulin (mab anti-tubb2a, t9026, sigma-aldrich) histon h3 (poab anti-hist3h3, 9715, cell signal technology) determin equal loading. membran subsequ incub 60 min room temperatur appropri fluoresc coupl secondari antibodi (irdye680cw-conjug goat anti- rabbit igg irdy 800cw-conjug goat anti-mous igg, li-cor biosciences, 92632,221 92632,210, respectively) dilut block buffer. 15-min wash step perform tbs-0.01% tween 20 (merck millipore). bound antibodi detect odyssei infrar imag (li-cor), densitometr analysi perform odyssei v.3 softwar (li-cor). fluoresc microscopi studi pb monocyt (105 cells/well) plate incub indic stimuli 72 h millicel ez slide (merck millipore). cell fix pb contain 4% paraform- aldehyd (panreac) incub 24 h 4c moab anti-cd5l (abnova) poab anti-lc3 (novu biologicals) pb contain 0.3% triton x-100 10% human ab serum (sigma-aldrich). cell subsequ incub 1 h room temperatur alexa fluor 488 f(ab)2 fragment goat anti-mous igg alexa fluor 647 f(ab)2 fragment goat anti- rabbit igg (molecular probes) pb contain 0.3% triton x-100. steps, unbound antibodi remov wash pbs. finally, nuclei stain 10 min room temperatur pb contain 800 nm hoechst 33,258 solut (sigma-aldrich). cell wash time pbs, coverslip mount fluoromount media (sigma-aldrich) left 4c overnight. determin autophag flux, cultur medium replac prewarm rpmi contain 100 nm lysotrack red (molecular probes), cell incub 37c 1 h fixation. slide examin axio observ z1 duo lsm 710 con- focal analyz zen black softwar (carl zeiss microscopi gmbh). lc3 lc3-lysotrack red coloc puncta cell determin green red puncta coloc macro imagej softwar threshold imag size 3 30 pixel2 puncta circular 0.81, describ previous (23). silenc cd5l, atg7, id3 express undifferenti thp1 cell transfect 10 nm set sirna target cd5l, atg7, id3 equal concentra- tion non-target neg control pool (on-target plu sirna, dharmacon) interferin (polyplus-transfect sa), previous describ (23), follow manufactur instructions. 24 h, medium replaced, cell differenti 24 h cultur medium supplement 10 ng/ml pma. next, medium replac cultur 7 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 medium 24 h test cd5l, atg7, id3 express pcr western blot function assai describ above. indicated, cell treat 40 ng/ml dxm addit 24 h prior analysis. gene express profil analysi total rna isol purifi 106 thp1-vector thp1-cd5l macrophag trizol reagent (invitrogen) rneasi column (qiagen). crna gener 10 g total rna superscript (invitrogen) messageamp ii-biotin (ambion, usa) rna transcription-label kit (enzo biochem) crna hybrid codelink human genom bioarrai (appli microarrays) 37c 16 h traymix hybrid (biotray, france). sampl label cy5 (bionova), arrai scan innoscan 700 scanner (innopsys). data normal analysi perform bioconductor r, limma packag bio- informat platform ciberehd, spain. microarrai data deposit ncbi gene express omnibu database( access number gse111315. list gene obtain microarrai analysi associ biolog process annotations, defin gene ontolog (go) consortium (18). david bioinformat resourc (19, 20) search statisti- calli signific enrich function categories. statist analysi data present mean sem experiments. student t-test perform graphpad prism v.5 software. valu p 0.05 consid significant. result polar cd5l promot m2 phenotyp profil like induc il10 gain thorough understand role cd5l human macrophag polarization, examin phenotyp function chang induc protein, compar respons cultur medium () standard polar stimuli ifn/lps, il4, il10. human pb monocyt thp1 macrophag express detect level cd5l protein. therefore, supplement pb monocyt cultur human rcd5l human alb control. inert protein, previous neg control, observ signific effect pb monocyt assays. hand, gener macrophag cell line stabli express human cd5l, refer thp1-cd5l (21, 24). initi analysi includ combin flow cytometri stud- i hladr, cd80, cd206, cd23, cd163 polar marker pb monocyt healthi blood donor treat- ment medium alone, standard polar stimuli, rcd5l (figur 1a). experiments, inf/lp select increas hladr cd80 diminish cd206 cd163 compar medium alone; il4 increas hladr, cd80, cd23, cd206 inhibit cd163; il10, rcd5l, increas cd163, reduc cd23. collectively, flow cytometri data build algorithm macrophag polar classification, facilit studi respons pattern unbias manner (tabl 1). end, flow cytometri data marker express normal (figur 1b). donor, respons compar normal profil ifn/lps, il4, il10 cal- culat distanc respons standard stimuli. shortest distanc consid optimal. minimum distanc criterion, 92% sampl treat ifn/lps, il4, il10 correctli classifi accord appli stimuli (ifn/lps, il4, il10) (figur 1c). classif algorithm compar distanc rcd5l-induc surfac marker level ( )imficd5l,d pattern standard stimuli (ifn/lps, il4, il10). criterion minimum distanc classifi 10 12 rcd5l-treat sampl (83%) il10-lik respons 2 (17%) ifn/lps-lik respons (figur 1c, right). therefore, accord algorithm, rcd5l promot phenotyp resembl il10 10 12 donors. rt-qpcr reinforc findings, show treatment pb monocyt rcd5l modifi cd80, tnf, cd206, tgm2 express induc predomin increas cd163, mer tyrosin kinas (mertk), cd36, vascular endotheli growth factor (vegf) mrna expression, similar wai il10 (figur 1d). analyz express select set gene thp1 macrophag il10 modifi signific manner. therefore, assai corticosteroid dxm addit m2-polar stimulu cells. thp1 macrophag respond ifn/lps, il4, dxm modul cd80, tgm2, cd163, mertk gene express similar wai pb monocyt (figur 1e). interestingly, thp1-cd5l mac- rophag show profil resembl thp1-vector macrophag treat il10 dxm. given stat3 kei transcript regul il10 (33), assess activation. western blot experi reveal increas stat3 phosphoryl (tyr705) pb monocyt polar il10 rcd5l compar incu- bate control human alb (figur 1f, left). similar result observ stat3 phosphoryl unstimul thp1-cd5l vs. control thp1-vector macrophag (figur 1f, right). taken together, data reinforc notion cd5l molecular driver m2 macrophag polarization. data suggest thp1 macrophag suitabl purpos present study. cd5l drive macrophag m2 function phenotyp similar induc il10 next, perform seri function experi determin rcd5l-polar pb monocyt (m-cd5l) share m-il10 m-dxm effector mechanisms. regard, like m-il10, m-cd5l secret lower level inflammatori mediat tnf, il1, il6 respons lps, sug- gest decreas inflammatori respons molecul figur 2 | cd5l, like il10, promot anti-inflammatori apoptot cell pro-phagocyt function macrophages. pb monocyt thp1 macrophag (a indicated) treat 72 h indic stimuli left untreat (), follow function test performed. (a) tnf, il1, il6 measur elisa cultur supernat polar macrophages, stimul 10 ng/ml lp 4 h tnf, 24 h il1 il6. graph mean sem blood donors, perform triplicates. (b) intracellular ro releas quantifi chang dcf fluorescence. mean sem fold chang rel unstimul cell () independ experi perform triplic shown. (c) pb monocyt incub 3 m latex microspher ratio 1:5 (pb monocytes: microspheres), escherichia coli staphylococcu aureu bioparticl ratio 1:10 (pb monocytes: bacteria) 1 h indic temperatures. percentag fitc-posit cell determin flow cytometry. data mean sem independ donors. (d) pb monocyt polar 72 h indic stimuli, deep red-stained, incub cfse-stain apoptot hepg2 cell ratio 1:2 (pb monocytes: apoptot cells) 1 h indic temperatures. percentag cfse-posit pb monocyt determin flow cytometry. graph show mean sem independ experiments. (e) fluoresc microscopi imag unstimul deep red-stain thp1-vector thp1-cd5l macrophag (purple) co-cultur apoptot cfse-hepg2 cell (green) 1 h 37c. data present mean sem. *p 0.05; **p 0.01; ***p 0.001 student t-test, vs. macrophag cultur medium () column. 8 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 (figur 2a). addition, il10 treatment reduc inflammatori ro production. interestingly, treatment rcd5l opposit effect, slightli increas ro level macrophag (figur 2b). studi addit function featur macrophages, phagocytosi latex bead bacteria, apoptot cell clearance. assays, percentag fitc-posit cell increas dose-depend manner experi perform 37c 4c (figur s1 supplementari material). observ indic increas fluoresc uptak adher cell surface. interestingly, unlik inhibitori effect ifn/lps, treatment il4, il10, rcd5l alter phagocytosi latex beads, gram-neg e. coli gram-posit s. aureu (figur 2c). contrary, analyz efferocyt abil rcd5l-polar macrophag observ respond increas phagocytosi apoptot hepg2 cells. regard, rcd5l il10 treatment increas popul fitc-posit cell figur 3 | cd5l express m2 macrophages. (a) rt-qpcr analysi cd5l express primari macrophag (left) thp1 macrophag treat indic stimuli 24 h. data mean valu blood donor independ experiments. (b) repres imag cd5l (green) primari macrophag treat indic stimuli 72 h. nuclei stain hoechst (blue). graph cd5l mean fluoresc intens (mfi) sem 50 macrophag score random fields. (c) analysi cd5l mrna level thp1-vector thp1-cd5l macrophag transfect sirna target cd5l (cd5l) non-target neg control (ct) 24 h treatment dexamethason (dxm). data mean valu independ experiments. (d) rel amount mrna encod cd80, tgm2, cd163, mer tyrosin kinas (mertk) measur rt-qpcr cd5l-silenc (cd5l) non-target neg ct transfect thp1-cd5l macrophag 24 h dxm treatment. data mean sem independ experiments. data present mean sem. *p 0.05; **p 0.01; ***p 0.001 student t-test. 9 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 46 25%, respectively, compar macrophag treat control protein alb (p = 0.008 p = 0.0011 student t-test, respectively) (figur 2d). similar result obtain compar thp1-cd5l thp1-vector macrophag (figur 2e; figur s1 supplementari material). altogether, data suggest cd5l drive macrophag anti-inflammatori high-efferocyt function phenotype, like shown m2, m-il10. cd5l express promot m2-polar stimuli determin express cd5l polar macrophages, analyz cd5l mrna protein pb monocyt polar inf/lps, il4, il10, dxm. lxr/rxr synthet ligand (t13+9cr) posit control cd5l upregula- tion, nuclear receptor induc cd5l express (19, 34). rt-qpcr data show cd5l mrna level upregul 9.31- 5.54-fold il10 dxm polarization, respectively, compar medium (figur 3a, left). accordingly, dxm-treat thp1-vector macrophag show 5.53-fold upregul cd5l mrna (figur 3a, right). upregul cd5l gene express associ increas protein expression, observ immunofluo- rescenc stain confoc microscopi anti-cd5l moab (figur 3b). studi particip cd5l acquisit m2 phenotype, silenc express dxm-treat thp1-vector macrophages. cd5l mrna induc- tion dxm cell abolish sirna transfect compar thp1-vector macrophag transfect control sirna (figur 3c). interestingly, abolit concomit diminish express m2 marker cd163 (by 56.8%) mertk (by 100%) (figur 3d). contrast, express m1 marker cd80 remain unaltered, sug- gest chang specific. altogether, data indic cd5l express m2 macrophages, reinforc notion cd5l contribut acquisit m2 phenotype. autophagi protein atg7 involv m-cd5l polar autophagi lc3-associ phagocytosi involv macrophag polar (3539). cd5l induc autophagi (23), examin autophag machineri involv cd5l-driven macrophag polarization. autophagi vesicl format fusion lysosom examin m-ifn/lps, m-il4, m-il10, m-dxm m-cd5l (figur 4a,b). end, measur lc3 puncta cell coloc lc3 puncta acid organelles, figur 4 | involv autophagi m-cd5l polarization. (a) 72-h treat pb monocyt stain specif lc3 antibodi (green), acid organel lysotrack red (purple), nuclei hoechst dye (blue). left panel: repres confoc microscopi imag show lc3 lysotrack red stain coloc yellow (merged). right graphs: mean sem quantit data show number lc3 puncta cell (lc3+ puncta/cell) lysotrack puncta cell (lt+ puncta/cell) lc3-lysotrack red coloc puncta cell (lc3+ lt+ puncta/cell) blood donors, includ 50 cell score random fields. (b) immuno-blot lc3i ii level 72-h treat pb monocytes. repres blot independ experiments. detect tubb2a measur equal loading. (c) analysi atg7 mrna level thp1-vector thp1-cd5l macrophages, untreat () transfect sirna target atg7 (atg7) non-target neg control (ct). data mean valu independ experiments. (d) rel amount mrna encod cd80, tgm2, cd163, mer tyrosin kinas (mertk) measur rt-qpcr untreat (), atg7-silenc (atg7), non- target neg control (ct) transfect thp1-cd5l macrophages. data mean valu independ experiments. (e) determin degre efferocytosi thp1-cd5l macrophages, non-target neg control transfect cell (ct), atg7-silenc cell co-cultur apoptot cfse-hepg2 cell 1 h indic temperatur ratios. data mean sem percentag fitc-posit cell independ experiments, determin flow cytometry. *p 0.05; **p 0.01; ***p 0.001 t-test (a,ce). 10 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 11 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 detect acidotrop fluoresc dye lysotrack red. polar il10, dxm, rcd5l triplic lc3 puncta cell (2.40 0.24, 2.87 0.29, 2.21 0.47, respectively, vs. 0.66 0.19) promot lysotrack red coloc (0.57 0.17, 0.41 0.16, 0.36 0.12 doubl posit puncta cell, respectively, vs. 0.008 0.008) compar treat- ment control protein alb. addition, cell exam- in microtubule-associ protein 1 light chain 3a/b (lc3)-ii statu western blot total cell lysat (figur 4b). assai reveal that, like il10 dxm, rcd5l-induc high lc3-ii levels, support notion increas autophagy-depend mechanisms. silenc express atg7, integr com- ponent cellular autophag machinery, thp1-cd5l macrophag observ phenotyp function conse- quences. experiments, sirna treatment led ~60% silenc atg7, previous report (23) (figur 4c). silenc atg7 inhibit cd163 mertk mrna 55 100%, respectively, compar express level thp1-vector macrophages, affect express m1 marker cd80 tgm2 (figur 4d). moreover, atg7 silenc reduc efferocyt capac thp1-cd5l mac- rophag 68% compar cell treat control non-target sirna thp1-vector macrophag activ- iti refer (figur 4e). data suggest autophag mechan particip cd5l-induc m2 macrophag phenotyp function. gene express profil analysi cd5l- express macrophag reveal id3 molecular target array-bas express profil experi perform compar thp1-vector thp1-cd5l macrophages. express 16 9 gene upregul downregulated, respectively, cd5l express (>2-fold induction, p < 0.01) (figur 5a). list gene modifi cd5l (>2-fold, p < 0.05) subject analysis. us david bio- informat resourc show statist signific enrich function categories, includ leukocyt migration, metabol processes, signal transduction, apoptosis, list gene modul cd5l (figur 5b). analyz express profil data identifi intracellular player cd5l-mediat macrophag polar select dna-bind protein inhibitor id3 (id3) transcript factor brain express x-link 1 (bex1), up- downregul genes, respect (fold chang vs. thp1-vector: id3 7.2 bex1 9.59, p < 0.0001). accordingly, rt-qpcr analysi reveal upregul id3 downreg- ulat bex1 thp1-cd5l vs. thp1-vector macrophag (figur 5c). interestingly, bex1 mrna downregul primari macrophag treatment (i.e., ifn/lps, il4, il10, rcd5l) compar incub medium (figur 5d, left). therefore, data indi- cate specif involv bex1 il10- cd5l-driven polarization. contrast, id3 express downregul macrophag treat ifn/lps, upregul treat il10 rcd5l (figur 5d, right). confirm cd5l-depend id3 upregul protein level western blot thp1 macrophag lysat (figur 5e, left), m-il10 m-cd5l (figur 5e, right) compar stimuli medium alone. altogether, data suggest cd5l il10 induc id3 express macrophages. studi modul id3 express cd5l mediat induct autophagi (figur 5f). blockad atg7 express thp1-cd5l macrophag partial revers id3 mrna induct (56% inhibition). taken together, result indic id3 mrna upregul il10- cd5l-polar mac- rophag express regulated, part, autophagy. id3 involv m-cd5l polar id3 transcript regul neg control basic helixloop-helix transcript factor form heterodim inhibit dna-bind transcript activity. determin contribut id3 cd5l-mediat polariza- tion, silenc express thp1-cd5l macrophag sirna treatment. observ ~91% inhibit id3 mrna (figur 6a, left) reduct id3 protein level cells, level observ control cell (thp1- vector) (figur 6a, right). decreas id3 express modifi cd80 cd163 expression, led 100% decreas mertk mrna levels, complet revers effect cd5l overexpress thp1 macrophag (figur 6b). accord decreas mertk expression, id3 silenc abolish effect cd5l efferocyt activ cell 99% (figur 6c). moreover, id3 silenc thp1-cd5l macrophag enhanc tnf il1 secret respons tlr induction, revers modulatori effect cd5l cytokin secret respons lp (figur 6d). data strongli support notion id3 transcript factor involv induct phenotyp function characterist m-cd5l. discuss macrophag polar character mice definit gene/protein signatur markers, secretori profiles, activ pathways, definit macrophag polar state human poorli characterized. here, conduct comprehens phenotyp function profil human pb monocyt thp1 cell treat standard polar stimuli us studi relat macrophag polarization. regard, prove util approach character macrophag respons cd5l. specifically, demonstr cd5l drive m2 macrophag polar similar manner il10. find relev m2 macrophag kei regul inflammatori heal responses, tumor progression. identifi novel molecul mechan involv human macrophag polar facilit discoveri novel diagnost therapeut tools. figur 5 | gene express profil analysi thp1-vector thp1-cd5l macrophages. (a) global effect cd5l overexpress thp1 cell line. thp1-vector (n = 2 replicates) thp1-cd5l (n = 3 replicates). heat-map gene up- downregul cd5l express (>2-fold induction, p < 0.05). posit (orange) neg (green) chang gene express control cell shown. (b) gene ontolog analysi list gene modul cd5l show signific enrich biolog processes. (c) rt-qpcr analysi brain express x-link 1 (bex1) id3 express thp1-vector thp1-cd5l macrophages. data mean valu independ experiments. (d) rt-qpcr analysi bex1 id3 express pb monocyt incub indic stimuli 24 h. data mean valu blood donors. (e) western blot id3 thp1-vector thp1-cd5l cell (left) 72 h-polar pb monocyt (right). repres blot independ experiments. detect hist3h3 measur equal loading. (f) level bex1 id3 mrna untreat () non-target sirna neg control transfect cell (ct) atg7-silenc (atg7) thp1 cells. data mean independ experiments. *p 0.05; **p 0.01; ***p 0.001 student t-test. 12 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 polar studies, includ express data mathemat analysi 5 surfac marker pb mono- cyte 26 healthi donors, agre literature. addition, provid global pictur phenotyp chang polarization. accordingly, observ m1 m-inf/lp show upregul hladr conjunct figur 6 | involv transcript factor id3 m-cd5l polarization. thp1 macrophag left untreat () transfect sirna target id3 (id3) non-target neg control (ct), follow function test performed: (a) rt-qpcr (left) western blot repres imag (right) id3 mrna protein silencing. rt-qpcr data mean independ experiments. detect hist3h3 measur equal load western blot experiments. (b) mrna encod cd80, cd163, mer tyrosin kinas (mertk) measur rt-pcr. data mean independ experiments. (c) analysi phagocytosi apoptot hepg2 cell flow cytometry. cfse-apoptot hepg2 cell co-cultur thp1 macrophag 1 h ratio 1:2 (thp1: apoptot cells). graph mean sem independ experiments. (d) amount tnf, il1, il6 measur elisa cultur supernat 4 h (for tnf) 24 h (for il1 il6) stimul 10 ng/ml lps. graph mean sem independ experi perform triplicates. *p 0.05; **p 0.01, ***p 0.001; student t-test. 13 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 co-stimulatori molecul cd80, indica- tive increas antigen present (8), downregul cd206, molecul relat resolut inflamm (40). m2 macrophages, m-il4 enhanc hladr cd80 expression, cd206 cd23, involv allerg reaction (41). surprisingly, il4, like ifn/lps, induc downregul cd163, wide accept marker m2 phenotyp (40). contrast, il10, m2 stimulus, upregul cd163 inhibit cd23. obtain global object valu phenotyp chang classifi macrophag polar basi specif treatment, develop mathemat algorithm. marker, defin uniqu quantit descriptor, normal imfi magnitude, imfi . magni- tude independ particular fluoresc scale dif- ferent marker assessed. therefore, imfi allow comparison effect (up- downregulation) differ stimuli marker regardless rel fluoresc signal used. quantifi distanc imfi marker donor stimuli com- pare mean profil vectors. approach, valid 92% agreement, prove us classifi polar macrophag basi global phenotype. believ qualifi method excel tool classif purpos 8% misclassif detect probabl relat inher heterogen humans. present algorithm allow quantit determin cd5l-induc macrophag surfac marker express profil similar m-il10 profile. however, distanc valu given cd5l slightli greater produc il10, suggest stimuli led global similar ident phenotyp responses. summary, newli develop algorithm prove us determin effect differ stimuli macrophag polarization. phenotyp chang observ flow cytometri com- plement rt-qpcr data. initi assai confirm chang cd80, cd206, cd163 mrna correl provid flow cytometry. therefore, rt-qpcr analysi follow addit subset-specif genes: tnf, main inflammatori cytokines; multifunc- tional enzym transglutaminas 2, mertk, scaveng receptor cd36, relat phagocytosi apoptot cell clearanc (40); vegf, involv angiogenesi (42). agreement previou findings, cd5l modul gene similar wai il10. 14 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 better understand effect polar treat- ment biolog function macrophages, exam- in function behavior cells. accord literatur (7), observ distinct secretori profil lp stimulation. m-inf/lp respond lp increas tnf, il1, il6 expression. contrast, m-il10 m-cd5l block inflammation, produc minimal, basal level cytokin respons lps. cd5l- il10-induc macrophag polar inhibit inflam- matori respons lp similar manner, data suggest effect cd5l caus direct induct il10 secretion, rcd5l effect il10 mrna protein level macrophag absenc tlr stimul (23). furthermore, anti-microbi respons involv ro product increas m-cd5l, contrast diminish level ro detect m-il10 (43). obser- vation reinforc idea cd5l act direct il10 induction. phagocytosi pathogens, apoptot cells, cell debri kei featur macrophag function host defens tissu homeostasis. set phagocytosi experi latex beads, bacteria, apoptot cells, observ suppress phagocyt activ m-inf/lps. find line report show inf-treat macrophag impair phagocyt activ (4446). conversely, m-il10 m-cd5l show elev express uptak receptor cd163, cd36, mertk, increas efferocytosis, observ consist find studi (47) reinforc role m2 macrophag resolut inflammation. altogether, phenotyp function data suggest cd5l drive macrophag polar anti-inflamma- tori pro-resolv phenotype. interestingly, vitro, cd5l express restrict il10- dxm-polar mac- rophages, point posit feedback loop cd5l express mainten m2 phenotype. increas bodi evid show autophag machineri regul macrophag polar (3539). however, discrep contribut autophagi m1 m2 polar (36, 48, 49). discrep explain differ experiment set and/or background macrophag studied. data show increas lc3 puncta lc3-lysotrack red-posit puncta cell, increas lc3-ii/-i ratio macrophag treat il10, dxm, rcd5l, sug- gest enhanc autophagi m2 macrophages. addit analys protein particip autophagi signal- ing (e.g., p62/sqstm1, mtor, ampk) necessari determin kei partner involved. moreover, role autophagi cd5l polarization, sirna experi target atg7 support notion that, involv anti-inflammatori function (23), autophagi plai kei role m2 marker express clearanc apoptot cell m-cd5l. identifi intracellular player involv cd5l-mediat polarization, perform express profil experi compar thp1-vector thp1-cd5l macrophages. thp1 cell line show similar result primari cell marker expression, stat3 activation, phagocytosis, efferocytosis. list gene modul cd5l show statist signific enrich function categories, previous relat cd5l func- tions, includ leukocyt migration, metabol processes, signal transduction, apoptosi (14), valid data. contribut id3 macrophag polariza- tion, posit feedback id3 m2 polar proposed, id3 upregul m2-polar stimuli, tgf (50), lung cancer-condit medium, galectin-1 (51). data line results, cd5l il10, m2 drivers, enhanc id3 expres- sion. accordingly, blockad experi support notion id3 involv anti-inflammatori function clearanc apoptot cell m-cd5l macrophages. interestingly, autophag flux block atg7 silenc thp1-cd5l cells, id3 upregul partial reversed, suggest upregul id3 autophagy-dependent. best knowledge, studi establish link id3 transcript factor autophagy. summary, report comprehens method analyz human macrophag polarization. approach reveal novel role cd5l driver m2 macrophag polar upregul id3 autophag mechanisms. result point cd5l potenti target futur therapi seek alter macrophag polar state. appli set cancer, reprogram tumor-associ macrophag promis mode treatment. ethic statement studi involv human sampl conduct follow declar helsinki principl current legisl confidenti person data approv human ethic committe hospit universitari german tria pujol. author contribut ls, ga, et, na perform experiments. ls, ga, m-r design experiments. ls m-r wrote manuscript. ls, ga, m-rs, ca analyz data. dl cp develop mathemat algorithm. author read, discussed, agre final version manuscript. acknowledg acknowledg annabel f. valledor (nuclear receptor group, univers barcelona) help discussion. thank marco fernndez, gerard requena, pilar armengol (flow cytometri microscopi unit, igtp), elisabet pedrosa (for- mer genet platform, igtp), juanjo lozano (bioinformat platform, ciberehd), marta valeri (microscopi platform, vall dhebron research institute) technic help. 15 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 fund work support grant fundaci la marat tv3 (mtv3 2013-3610) instituto salud carlo iii (isciii), erdf (fi ip10/01565, ip13/1906, ip16/0974, fi ip13/02340 m-r ca, respectively). et receiv scholarship igtp. m-r ca support agaur 2017-sgr-490, miguel servet (cpii14/00021), ramn y cajal (ryc-2010-07249) programs, respectively. igtp member cerca network institutes. supplementari materi supplementari materi articl onlin full#supplementary-material. refer 1. gordon s, plddemann a. tissu macrophages: heterogen functions. bmc biol (2017) 15:53. doi:10.1186/s12915-017-0392-4 2. wynn ta, chawla a, pollard jw. macrophag biologi development, homeostasi disease. natur (2013) 496:44555. doi:10.1038/nature12034 3. stout rd, jiang c, matta b, tietzel i, watkin sk, suttl j. macrophag sequen- tialli chang function phenotyp respons chang microen- vironment influences. j immunol (2005) 175:3429. doi:10.4049/jimmunol. 175.1.342 4. mill cd. m1 m2 macrophages: oracl health disease. crit rev immunol (2012) 32:46388. doi:10.1615/critrevimmunol.v32.i6.10 5. schultz jl. reprogram macrophagesnew opportun therapeut targeting. curr opin pharmacol (2016) 26:105. doi:10.1016/j. coph.2015.09.007 6. edward jp, zhang x, frauwirth ka, mosser dm. biochem function character activ macrophag populations. j leukoc biol (2006) 80:1298307. doi:10.1189/jlb.0406249 7. martinez fo, gordon s. m1 m2 paradigm macrophag activation: time reassessment. f1000prime rep (2014) 6:13. doi:10.12703/p6-13 8. murrai pj, allen je, biswa sk, fisher ea, gilroi dw, goerdt s, et al. macrophag activ polarization: nomenclatur experiment guidelines. immun (2014) 41:1420. doi:10.1016/j.immuni.2014.06.008 9. jablonski ka, amici sa, webb lm, ruiz-rosado jdd, popovich pg, partida- sanchez s, et al. novel marker delin murin m1 m2 macrophages. plo (2015) 10:e0145342. doi:10.1371/journal.pone.0145342 10. zhou d, huang c, lin z, zhan s, kong l, fang c, et al. macrophag polariza- tion function emphasi evolv role coordin regula- tion cellular signal pathways. cell signal (2014) 26:1927. doi:10.1016/j. cellsig.2013.11.004 11. galvn-pea s, oneil laj. metabol reprogram macrophag polariza- tion. immunol (2014) 5:420. doi:10.3389/fimmu.2014.00420 12. ivashkiv lb. epigenet regul macrophag polar function. trend immunol (2013) 34:21623. doi:10.1016/j.it.2012.11.001 13. gebe ja, kiener pa, ring hz, li x, franck u, aruffo a. molecular cloning, map human chromosom 1 q21-q23, cell bind characterist spalpha, new member scaveng receptor cysteine-rich (srcr) famili proteins. j biol chem (1997) 272:61518. doi:10.1074/jbc.272.10.6151 14. sanjurjo l, aran g, roher n, valledor af, sarria m-r. aim/cd5l: kei protein control immun homeostasi inflammatori disease. j leukoc biol (2015) 98:17384. doi:10.1189/jlb.3ru0215-074r 15. qu p, du h, li y, yan c. myeloid-specif express api6/aim/sp alpha induc system inflamm adenocarcinoma lung. j immunol (2009) 182:164859. doi:10.4049/jimmunol.182.3.1648 16. zou t, garifulin o, berland r, boyartchuk vl. listeria monocytogen infec- tion induc prosurviv metabol signal macrophages. infect immun (2011) 79:152635. doi:10.1128/iai.01195-10 17. haruta i, kato y, hashimoto e, minjar c, kennedi s, uto h, et al. associ aim, novel apoptosi inhibitori factor, hepat support mac- rophag surviv enhanc phagocytot function macrophages. j biol chem (2001) 276:229104. doi:10.1074/jbc.m100324200 18. arai s, shelton jm, chen m, bradlei mn, castrillo a, bookout al, et al. role apoptosi inhibitori factor aim/sp/api6 atherosclerosi development. cell metab (2005) 1:20113. doi:10.1016/j.cmet.2005.02.002 19. joseph sb, bradlei mn, castrillo a, bruhn kw, mak pa, pei l, et al. lxr- depend gene express import macrophag surviv innat immun response. cell (2004) 119:299309. doi:10.1016/j.cell.2004.09.032 20. li y, qu p, wu l, li b, du h, yan c. api6/aim/sp{alpha}/cd5l overexpress alveolar type ii epitheli cell induc spontan lung adenocarcinoma. cancer re (2011) 71:548899. doi:10.1158/0008-5472.can-10-4225 21. sanjurjo l, amzaga n, vilaplana c, ccere n, marzo e, valeri m, et al. scaveng protein apoptosi inhibitor macrophag (aim) poten- tiat antimicrobi respons mycobacterium tuberculosi enhanc autophagy. plo (2013) 8:e79670. doi:10.1371/journal.pone. 0079670 22. sarria m-r, rosel s, snchez-barbero f, sierra jm, vila j, ylamo j, et al. role human sp alpha pattern recognit receptor. j biol chem (2005) 280:353918. doi:10.1074/jbc.m505042200 23. sanjurjo l, amzaga n, aran g, naranjo-gmez m, aria l, armengol c, et al. human cd5l/aim-cd36 axis: novel autophagi induc macrophag modul inflammatori responses. autophagi (2015) 11:487502. doi:10.1080/15548627.2015.1017183 24. amzaga n, sanjurjo l, julv j, aran g, perez-cabeza b, bastos-amador p, et al. human scaveng protein aim increas foam cell format cd36- mediat oxldl uptake. j leukoc biol (2014) 95:50920. doi:10.1189/jlb. 1212660 25. sarria mr, padilla o, monreal y, carrasc m, abian j, vive j, et al. biochem character recombin circul human spalpha. tissu antigen (2004) 63:33544. doi:10.1111/j.0001-2815.2004.00193.x 26. won kk, hwang h-r, hk, phil yl, yu ji, ryu h-y, et al. glycoproteom analysi plasma patient atop dermatitis: cd5l apo potenti biomarkers. exp mol med (2008) 40:67785. doi:10.3858/emm. 2008.40.6.677 27. gangadharan b, antrobu r, dwek ra, zitzmann n. novel serum bio- marker candid liver fibrosi hepat c patients. clin chem (2007) 53:17929. doi:10.1373/clinchem.2007.089144 28. mera k, uto h, mawatari s, ido a, yoshimin y, nosaki t, et al. serum level apoptosi inhibitor macrophag associ hepat fibrosi patient chronic hepat c. bmc gastroenterol (2014) 14:27. doi:10.1186/1471-230x-14-27 29. grai j, chattopadhyai d, beal gs, patman gl, miel l, king bp, et al. proteom strategi identifi novel serum biomark liver cirrhosi hepatocellular cancer individu fatti liver disease. bmc cancer (2009) 9:271. doi:10.1186/1471-2407-9-271 30. iannaccon a, hollingsworth tj, koirala d, new dd, lenchik ni, beranova- giorgianni s, et al. retin pigment epithelium microglia express cd5 antigen-lik protein, novel autoantigen age-rel macular degeneration. exp ey re (2017) 155:6474. doi:10.1016/j.exer.2016.12.006 31. wang c, yosef n, gaublomm j, wu c, lee y, clish cb, et al. cd5l/aim regul lipid biosynthesi restrain th17 cell pathogenicity. cell (2015) 163:141327. doi:10.1016/j.cell.2015.10.068 32. miyazaki t, hirokami y, matsuhashi n, takatsuka h, naito m. increas suscept thymocyt apoptosi mice lack aim, novel murin macrophage-deriv solubl factor belong scaveng receptor cys- teine-rich domain superfamily. j exp med (1999) 189:41322. doi:10.1084/ jem.189.2.413 33. yamaoka k, otsuka t, niiro h, nakashima h, tanaka y, nagano s, et al. select dna-bind activ interleukin-10-stimul stat mol- ecul human monocytes. j interferon cytokin re (1999) 19:67985. doi:10.1089/107999099313839 34. valledor af, hsu l, ogawa s, sawka-verhel d, karin m, glass ck. activ liver x receptor retinoid x receptor prevent bacterial-induc mac- rophag apoptosis. proc natl acad sci u s (2004) 101:178138. doi:10.1073/ pnas.0407749101 175.1.342 175.1.342 1212660 1212660 16 sanjurjo et al. cd5l drive m2 macrophag polar frontier immunolog | www.frontiersin.org march 2018 | volum 9 | articl 480 35. chen p, cescon m, bonaldo p. autophagy-medi regul mac- rophag applic cancer. autophagi (2014) 10:192200. doi:10.4161/auto.26927 36. yang m, liu j, shao j, qin y, ji q, zhang x, et al. cathepsin s-mediat autophag flux tumor-associ macrophag acceler tumor develop promot m2 polarization. mol cancer (2014) 13:43. doi:10.1186/1476-4598-13-43 37. chang c-p, su y-c, hu c-w, lei h-y. tlr2-depend select autophagi regul nf-b lysosom degrad hepatoma-deriv m2 mac- rophag differentiation. cell death differ (2013) 20:51523. doi:10.1038/ cdd.2012.146 38. liu k, zhao e, ilya g, lalazar g, lin y, haseeb m, et al. impair macrophag autophagi increas immun respons obes mice promot proin- flammatori macrophag polarization. autophagi (2015) 11:27184. doi:10.10 80/15548627.2015.1009787 39. heckmann bl, boada-romero e, cunha ld, magn j, green dr. lc3- associ phagocytosi inflammation. j mol biol (2017) 429:356176. doi:10.1016/j.jmb.2017.08.012 40. roszer t. understand mysteri m2 macrophag activ marker effector mechanisms. mediat inflamm (2015) 2015:816460. doi:10.1155/2015/816460 41. vercelli d, jabara h, lee b-w, woodland n, geha r, leung d. human recom- binant interleukin 4 induc fcer/cd23 normal human monocytes. j exp med (1988) 167:140616. doi:10.1084/jem.167.4.1406 42. newman ac, hugh ccw. macrophag angiogenesis: role wnt signaling. vasc cell (2012) 4:13. doi:10.1186/2045-824x-4-13 43. mill el, oneil la. reprogram mitochondri metabol mac- rophag anti-inflammatori signal. eur j immunol (2016) 46:1321. doi:10.1002/eji.201445427 44. shepherd vl, cowan hb, abdolrasulnia r, vick s. dexamethason block interferon-gamma-medi downregul macrophag man- nose receptor. arch biochem biophi (1994) 312:36774. doi:10.1006/abbi. 1994.1321 45. tariqu aa, logan j, thoma e, holt pg, sly pd, fantino e. phenotypic, function plastic featur classic altern activ human macrophages. j respir cell mol biol (2015) 53:67688. doi:10.1165/ rcmb.2015-0012oc 46. wang z, zhou s, sun c, lei t, peng j, li w, et al. interferon- inhibit non- opson phagocytosi macrophag mtorc1-c/ebp pathway. j innat immun (2015) 7:16576. doi:10.1159/000366421 47. korn d, frasch sc, fernandez-boyanap r, henson pm, bratton dl. modul macrophag efferocytosi inflammation. immunol (2011) 71:548899. doi:10.3389/fimmu.2011.00057 48. guo y, lin c, xu p, wu s, fu x, xia w, et al. ag induc autophagi impair cutan wound heal stimul macrophag polar m1 diabetes. sci rep (2016) 6:36416. doi:10.1038/srep36416 49. chang cp, su yc, lee ph, lei hy. target nfkb autophagi polar hepatoma-associ macrophag differentiation. autophagi (2013) 9:61921. doi:10.4161/auto.23546 50. gratchev a, kzhyshkowska j, kannookadan s, ochsenreit m, popova a, yu x, et al. activ tgf-beta-specif multistep gene express program matur macrophag requir glucocorticoid-medi surfac express tgf-beta receptor ii. j immunol (2008) 180:655365. doi:10.4049/jimmunol. 180.10.6553 51. kuo p-l, hung j-y, huang s-k, chou s-h, cheng d-e, jong y-j, et al. lung cancer-deriv galectin-1 mediat dendrit cell anergi inhibitor dna bind 3/il-10 signal pathway. j immunol (2011) 186:152130. doi:10.4049/jimmunol.1002940 conflict statement: author declar research con- duct absenc commerci financi relationship constru potenti conflict interest. copyright 2018 sanjurjo, aran, tllez, amzaga, armengol, lpez, prat sarrias. open-access articl distribut term creativ common attribut licens (cc by). use, distribut reproduct forum permitted, provid origin author(s) copyright owner credit origin public journal cited, accord accept academ practice. use, distribut reproduct permit compli terms. 1994.1321 1994.1321 180.10.6553 180.10.6553 cd5l promot m2 macrophag polar autophagy-medi upregul id3 introduct materi method primari cell cell line vitro polar macrophag multicolor flow cytometri analysi algorithm develop classif polar macrophag basi phenotyp respons ifn/lps, il4, il10 rna extract quantit rt-pcr measur cytokin secret ro measur analysi phagocytosi flow cytometri induct apoptosi efferocytosi assai western blot analysi cell lysat fluoresc microscopi studi silenc cd5l, atg7, id3 express gene express profil analysi statist analysi result polar cd5l promot m2 phenotyp profil like induc il10 cd5l drive macrophag m2 function phenotyp similar induc il10 cd5l express promot m2-polar stimuli autophagi protein atg7 involv m-cd5l polar gene express profil analysi cd5l-express macrophag reveal id3 molecular target id3 involv m-cd5l polar discuss ethic statement author contribut acknowledg fund supplementari materi refer